Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine.

Dheir, H; Sipahi, S; Cakar, G C; Yaylaci, S; Hacibekiroglu, T; Karabay, O

Dheir, H; Sipahi, S; Cakar, G C; Yaylaci, S; Hacibekiroglu, T; Karabay, O.

Dheir H; Division of Nephrology, Faculty of Medicine, Sakarya University, Sakarya, Turkey. hamaddheir@sakarya.edu.tr.

Eur Rev Med Pharmacol Sci ; 25(20): 6171-6173, 2021 10.

Article in English | MEDLINE | ID: covidwho-1503067

Subject(s)

Acute Kidney Injury/immunology; COVID-19 Vaccines/adverse effects; COVID-19/immunology; Nephritis, Interstitial/immunology; Acute Kidney Injury/pathology; Adult; BNT162 Vaccine; COVID-19/pathology; COVID-19 Vaccines/immunology; Female; Humans; Nephritis, Interstitial/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / COVID-19 Vaccines / COVID-19 / Nephritis, Interstitial Type of study: Case report Topics: Vaccines Limits: Adult / Female / Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2021 Document Type: Article Affiliation country: Eurrev_202110_26985

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google